Trial
NCT00896025
Study of N-Acetylcysteine in Acute Liver Failure (ALF)
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
Acute Liver Failure
Intervention
N-acetylcysteine
Why stopped
This observational study was stopped after 140 patients were enrolled, no more funds available to continue.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-06-01